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Practical Tips for Nephrologists 
 Intradialytic exercise increases phosphate clearance and may be a potential 
adjunct therapy for patients with inadequate phosphate control. 
 For practitioners looking to implement intradialytic exercise for improved 
phosphate control, the current evidence suggests light to moderate intensity 
intradialytic cycling exercise during most if not all weekly dialysis sessions.   
Future Research 
 The effects of intradialytic exercise on the clearance of toxic middle molecule and 
protein bound solutes warrants investigation. 
 Future studies should investigate if intradialytic exercise is effective at improving 
solute removal in patients receiving inadequate dialysis (Kt/Vurea <1.2).  
 Future studies aimed at improving patient centered outcomes should investigate 
whether intradialytic exercise could help alleviate the pill burden associated with 
phosphate control.        
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ABSTRACT 
 
Dialysis adequacy is an independent predictor of high mortality rates in hemodialysis 
patients. Intradialytic exercise is a potential strategy to increase uremic solute removal by 
increasing blood flow to low perfusion tissue beds. The purpose of this review is to establish 
the efficacy of intradialytic exercise for hemodialysis adequacy. Additionally, this review aims 
to provide practical information to aid health care professionals implement intradialytic exercise 
for dialysis adequacy.  
Database and hand searches identified 15 published interventional studies that 
implemented intradialytic exercise for dialysis adequacy as a primary outcome measure in 
adult maintenance hemodialysis patients. Data pertaining to dialytic solute clearance of urea, 
creatinine, beta2 microglobulin, phosphate and potassium were extracted. Mean differences, 
normalized to percentages, and effect sizes were calculated and reported.   
The current data pertaining to the use of intradialytic exercise for improving dialysis 
adequacy in terms of Kt/Vurea or small molecule uremic toxin clearance is equivocal. Limited 
data showed that intradialytic exercise has no effect middle molecule toxin (beta2 - 
microglobulin) clearance. Intradialytic exercise favored increased phosphate removal showing 
medium to large effects for reduced serum concentrations, reduced rebound and increased 
clearance. 
In summary, supervised light to moderate intradialytic aerobic cycling appears to be 
beneficial for increasing phosphate removal and may be an adjunct therapy for patients failing 
to meet clinical phosphate targets. Further work is required to establish the effect of 
intradialytic exercise on Kt/Vurea and other middle molecule and protein bound solutes. 
Research aimed at establishing the most effective exercise prescription for improved solute 
clearance is warranted.  
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INTRODUCTION 
The prevalence of end stage renal disease (ESRD) has increased dramatically by 86% 
over the past two decades in the United States 1. Hemodialysis is the most popular form of 
renal replacement therapy, with 87% of ESRD patients receiving this treatment modality 1. 
Despite substantial medical and pharmacological advances in renal replacement therapies, 
dialysis patients continue to have strikingly higher mortality rates compared to the general 
population and Medicare populations with cancer, diabetes or cardiovascular disease 1. The 
dose and adequacy of hemodialysis, typically determined by uremic solute clearance, is an 
independent predictor of this high mortality rate. Traditional strategies for improving dialysis 
adequacy involve increasing the dialysis time or frequency, both of which are limited by patient 
compliance and cost implications. Improving dialysis adequacy, therefore, remains a major 
challenge for nephrologists that warrants novel therapeutic approaches.  
One such potential strategy that has gained attention over the past decade is 
intradialytic exercise. The underlying physiological rationale for intradialytic exercise to improve 
dialysis adequacy is the associated increase in blood flow to the skeletal muscle, which holds 
a large proportion of the total body water and would ordinarily be a low perfused tissue bed 
during hemodialysis.  In support of this rationale, equation modelling that simulates the 
hyperemic effects of intradialytic exercise has predicted that increasing blood flow to low 
perfusion tissue beds will increase solute clearance and almost entirely eliminate post dialysis 
urea rebound 2. Additionally, other prediction equations have suggested that 60 minutes of 
intradialytic exercise may be equivalent to the traditional prescription of increasing dialysis time 
by 20-30 minutes in terms of solute clearance 3.  
Dialysis dose and adequacy is clinically quantified by Kt/Vurea, an index representing 
urea clearance throughout a dialysis session that is proportional to total body water. Current 
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KDOQI guidelines recommend a target single pool Kt/Vurea (spKt/V) of 1.4 per hemodialysis 
session, with a minimum delivered dose of 1.2 4.  The clearance of urea is clinically utilized as 
a marker of uremic solute removal as its blood concentration is increased in uremia; it has a 
low molecular weight allowing for an easy transfer across the dialysis membrane and rapid 
compartmental diffusion; and it is a water-based solute that allows the implementation of a 
single pool model representation of total body water. However, the use of urea as the sole 
representation of dialysis adequacy remains controversial and may represent an oversimplified 
view of dialysis adequacy 5. In this respect, urea does not represent the kinetic behavior of 
more toxic water-based solutes such as phosphate 6, or that of ‘middle molecules’ and protein 
bound solutes whose harmful effects are associated with inflammation, oxidative stress and 
cardiovascular disease 7.  
The purpose of this review is to provide an analysis of the literature that has reported 
indices of dialysis adequacy, including the removal of solutes other than urea, in association 
with intradialytic exercise in maintenance hemodialysis patients. The aim of the review is to 
establish a) the evidence base of the efficacy of intradialytic exercise for dialysis adequacy; b) 
the most effective exercise prescription parameters that may help guide health professional 
looking to implement intradialytic exercise for dialysis adequacy c) areas that warrant future 
research in this field.   
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METHODS 
Literature Search  
Pubmed database and hand searches were performed by one non-blinded author (DK) 
between August and November 2018. Searches utilized key terms relating to the disease 
condition (e.g. hemodialysis; renal failure, chronic), the intervention (e.g. intradialytic exercise; 
exercise therapy) and the outcome (e.g. dialysis adequacy; solute removal). From the results, 
one non-blinded author (DK) selected the relevant literature based on pre-determined criteria. 
Literature was excluded if it was a conference abstract or short communication; was a review 
paper; was not a peer reviewed published article; dialysis adequacy was not the primary 
outcome of interest; the exercise intervention was not intradialytic; included individuals <18 
years; not published in English; did not report outcome measures relating to dialysis adequacy; 
included an additional intervention coupled with exercise (e.g. nutraceutical, transcutaneous 
electrical muscle stimulation); a duplicate; involved animal models or computer modeled 
simulations. During a hemodialysis session, there are many treatment parameters that can be 
changed that may greatly affect solute removal (e.g. blood flow rate, dialysate flow rate; 
treatment time). For this reason, we chose only to include studies that investigated the effects 
of intradialytic exercise on dialysis adequacy as the primary outcome as these studies would 
typically control these treatment variables. Studies that implemented dialysis adequacy for 
other outcomes (e.g. body composition, physical function, cardiovascular function) that 
reported a marker of dialysis adequacy as a secondary outcome were excluded as 
uncontrolled dialysis treatment parameters may potentially bias the interpretation.      
 
Data Extraction 
 For each included study, the mean differences in outcome measures pertaining to 
dialysis adequacy or solute removal were extracted and normalized to percent changes. Effect 
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sizes were then calculated as (post intervention – pre intervention) / baseline or control group 
standard deviation 8. For intervention studies with a comparable control arm, interaction effect 
sizes were subsequently calculated as (experimental effect size – control effect size) / 2 8. 
Effects sizes were interpreted as small (0.2), medium (0.5) or large (0.8).  
 Data pertaining to serum values and indices of dialysis adequacy and solute clearance 
(Table 1) for the following uremic solutes was extracted: 
1) Small molecules: urea and creatinine. Urea and creatinine are both small molecule, 
water based solutes whose clearance represents a clinical marker of dialysis adequacy. 
Urea clearance is the currently the ‘gold standard’ clinical marker of dialysis adequacy 
and its clearance during dialysis is independently associated with survival 9. 
2) Middle molecule: beta-2-microglobulin (B2M). B2M is the representative marker of 
middle molecule uremic toxins. Middle molecule uremic toxins are associated with 
systemic toxicity with their accumulation predisposing patients to infection 6. Increased 
serum concentrations of B2M are associated with infectious related mortality 10.  
3) Inorganic substance: phosphate. Phosphate is a water-based solute that is the 
representative marker of inorganic substances. Increased serum phosphate levels are 
related to cardiovascular complications and are independently associated with mortality 
11.  
4) Electrolyte: potassium. Potassium is the most frequently reported electrolyte in terms 
of dialysis clearance. Increased levels of serum potassium are causally related to 
cardiovascular related mortality 12.  
 
Bias Reporting 
Risk of bias for each study was determined by two non-blinded authors (DK, MS) based 
on 1) Selection Bias 2) Performance Bias 3) Detection Bias and 4) Attrition Bias. Each factor 
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was given a score of 1 (high risk/not known), 2 (medium risk) or 3 (low risk) and an overall 
composite score from A (low risk) to C (high risk) was administered.   
 
RESULTS 
Included Study Designs 
A total of 15 studies were included in the review (Figure 1; Table 2).  Eight studies 
investigated the effects of an acute bout of exercise on dialysis adequacy 3,13-19, whilst seven 
studies performed a chronic intradialytic intervention 20-26.  Seven of the acute studies utilized a 
within subject crossover design 3,14-19, with six of the seven randomizing the treatment order. 
One acute study implemented a randomized controlled design13. Four of the intervention 
studies performed a randomized controlled trial20,22,23,25, one study utilized a within subject 
crossover design24, and two studies observed pre and post changes in an intervention group 
without a control comparison arm (1 group intervention)21,26.  
Bias scoring showed an intermediate bias risk (B) for 67% of the studies, followed by a 
high risk (C) and low risk (A) reported in 20% and 13% of the studies, respectively (Table 3). 
Reassuringly, the majority of studies implemented a randomized crossover design ensuring an 
intermediate to low risk of selection and performance biases. Unfortunately, many studies 
failed to detail the randomization strategy. Overall, the majority of studies did not mention if 
outcome assessors were blinded to treatment allocation, thereby presenting a high risk of 
detection bias. No studies performed an intention to treat analyses.   
 
Participant Characteristics 
Data from 307 patients were included. Participants included both males and females 
with ages ranging from 18 years15,22 to 76 years 22. Hemodialysis vintage ranged from 16 
months21 to 58 months14. The majority of patients dialyzed 3 times per week for 3– 4 hours. 
 9 
Mean dialysis dose reported as spKt/Vurea ranged from 0.9 23 to 1.8 25. Many studies did not 
report co-morbidities but excluded patients with contraindications to exercise. 
 
Exercise Interventions 
Most studies implemented aerobic exercise, with intradialytic cycling being the most 
common modality of exercise. The use of a mini-stepper was also included in one study26. 
Aerobic exercises were prescribed at light to moderate intensities ranging from 20 minutes – 
180 minutes. The duration of chronic interventions ranged from 8 – 12 weeks.  
Lower body resistance exercises were implemented in one chronic intervention study 
lasting 8 weeks 21. This type of exercise was performed utilizing venous anti statis slippers, 2-3 
dialysis sessions per week for 60 minutes at an unknown intensity  
An additional exercise modality included 15 minutes of range of motion exercises, which 
was implemented in two intervention studies lasting 8 weeks22,23. 
Most exercise interventions were prescribed during the first two hours of hemodialysis. 
Four studies allowed exercise into the third hour of dialysis 15,20,21,25. One study specifically 
prescribed exercise in the last half of dialysis 16.  
 
Harms 
 Only five studies actively reported harms14,16,25,26. No serious or unexpected adverse 
events relating to exercise were reported. Expected adverse events that were reported in a 
relatively small number of cases included episodic hypotension 16,25,26 and intradialytic 
cramping 14,16. 
 
Dialysis Adequacy: Small molecule toxins urea and creatinine 
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 Seven14,16-19,24,25 of the 13 studies that reported spKt/Vurea showed no statistical 
significance and small effect sizes for intradialytic exercise. Six3,15,20,21,23,26 of the 13 studies 
that reported spKt/Vurea favored intradialytic exercise with statistical significance or a large 
effect size. Only three studies reported eKt/Vurea 14,16,25, all of which showed intradialytic 
exercise to have no effect. Data pertaining to urea reduction ratios is equivocal with four 
studies showing statistical significance or a large effect size in favor of exercise3,15,23,26 and five 
studies showing exercise to have little to no effect14,16,17,19,25. The majority of studies that report 
urea rebound16,18,19, small molecule toxin dialysate clearance13,16-18 and creatinine removal 
13,16,18,25 show intradialytic exercise to have little to no effect. Studies that reported intradialytic 
exercise to be efficacious at improving Kt/Vurea and/or small molecule clearance 3,15,20,21,23,26 
overall had a higher risk of bias compared to those who reported exercise to have no effect 
14,16-19,24,25.  In summary, the slight majority of the research tends to lean towards intradialytic 
exercise having little to no effect on small molecule toxin clearance, however, overall the data 
is equivocal. 
 
Dialysis Adequacy: Middle molecule toxin Beta-2-Microglobulin 
Only one acute intervention reported the effects of B2M clearance and serum 
concentrations 16. This study showed intradialytic exercise to have no effect on this marker of 
middle molecule toxins.  
 
Dialysis Adequacy: Phosphate 
 Six 13,14,16,17,22,24 of seven18 of studies showed a statistically significant result or a 
medium-large effect size for increased phosphate clearance and/or improved serum 
concentrations with intradialytic exercise. Two studies showed that intradialytic exercise was 
more efficacious than a longer dialysis treatment time for increasing phosphate removal 16,17.  
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Dialysis Adequacy: Potassium 
Five3,13,22,24,25 of seven18,20 studies showed a statistically significant result or a large 
effect size for increased potassium clearance and/or reduced serum concentrations with 
intradialytic exercise.  
 
DISCUSSION 
 
Efficacy of Intradialytic Exercise for Dialysis Adequacy 
Contrary to physiological hypotheses and simulated mathematical modelling2, this 
review of the current literature trends towards a lack of efficacy for intradialytic exercise to 
improve Kt/Vurea and enhance small molecule uremic toxin clearance. These data, however, 
are contradictory and require follow up. There is currently insufficient data to determine the 
effect of intradialytic exercise on middle molecule and protein bound uremic toxin clearance. 
Interestingly, intradialytic exercise appears to be efficacious at improving phosphate kinetics 
and removal. In addition, intradialytic exercise holds promise for improving potassium balance 
and removal. 
Small Molecule Toxins. In order to explain the equivocal findings in relation to small 
and middle molecule clearance with intradialytic exercise, it is important to consider the current 
models of uremic toxin kinetics. With regards to small molecules urea and creatinine, the 
physiological hypotheses and mathematical models that predict intradialytic exercise to be 
efficacious at improving dialysis adequacy are based on a parallel regional blood flow kinetic 
model that separates organ systems to high or low flow systems based on their perfusion 
during dialysis 27,28. An alternative model is the classic serial diffusion model that incorporates 
a total body distribution of urea and stipulates that there is a rapid transfer of small molecules 
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from the intracellular to the extracellular compartments resulting in a precipitous equilibration of 
whole-body concentrations 29. According to this model, intracorporal changes in blood flow 
would not affect small molecule kinetics and may therefore explain why intradialytic exercise is 
not efficacious at improving dialysis adequacy in terms of small molecule clearance in the 
slight majority of studies.  
Middle Molecules Toxins. With regards to middle molecules such a B2M and protein 
bound molecules, their high transfer coefficient resulting in slower intercompartmental transfer 
would appear to be the rate limiting factor of their removal 30. Therefore, in terms of increasing 
removal of these solutes, increased cardiac output and blow flow to low perfusion regions 
would be less important than toxin distribution volume and intercompartmental clearance 
coefficients 31. Although the effects of exercise on middle molecule clearance were only 
investigated in one study16, this may explain the negligible effects observed regarding B2M 
kinetics.  
Inorganic substances. In comparison, intradialytic exercise appears to beneficial for 
phosphate removal. A four-pool model explains the biphasic regulation of phosphate kinetics 
during dialysis whereby extra phosphate is generated by erythrocytes and bone when 
phosphate levels become low32. It has previously been speculated that during intradialytic 
exercise phosphate is produced from skeletal muscle metabolism33 and therefore prohibits the 
need for increased phosphate generation from the erythrocytes and bone16. After exercise, 
phosphate released from the skeletal muscle is then utilized for energy replenishment leading 
to reduced serum phosphate levels16.  
Electrolytes. During exercise, there is a release of potassium ions from the skeletal 
muscle thereby decreasing intracellular concentrations and increasing plasma 
concentrations34. To maintain whole body homeostasis, sodium potassium pumps are typically 
activated to increase potassium uptake and prevent serum concentrations from rising to toxic 
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levels34. During intradialytic exercise however, it is possible that the increased serum 
potassium is removed via the dialyzer, thus reducing the intracellular re-uptake. This could 
potentially explain the observed decrease in potassium serum concentrations and increased 
removal that are observed with intradialytic exercise.   
 
Exercise Interventions. While the majority of studies have implemented aerobic 
cycling exercise at a light to moderate intensity, there is a large amount of variation in the 
exercise parameters between studies to establish what the most effective exercise prescription 
for dialysis adequacy is. Along with the intradialytic kinetics, it is also important to consider 
aspects of the exercise prescription that may lead to more effective solute removal. For 
example, exercise intensities prescribed below the lactate threshold may be more appropriate 
as decreases in blood pH may alter intercompartmental shifts of solutes and therefore affect 
their removal during dialysis35. In addition, during the first half of dialysis, the dialyzer 
clearance capacity is the rate limiting factor of removal2 and therefore exercise during the 
second half of dialysis, once a large portion of solutes have already been removed, may be 
more effective. If exercise prescription is based on previous mathematical simulations, then 
exercise needs to performed for at least 60 minutes to substantially affect urea rebound2.  
The exercise prescription parameters deemed most efficacious at altering solute 
kinetics and potentially increasing solute removal therefore warrant further investigation. One 
study by Parsons et al.25 included a small pilot study that established intradialytic cycling or 
use of a mini-stepper more effective at increasing urea removal compared to resistance 
exercise with ankle weights. No other studies have compared exercise prescription 
parameters. 
Finally, the exercise response in this population needs to be fully understood to provide 
effective exercise prescription. For example, hemodialysis patients have impaired cardiac 
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function36, vascular endothelial dysfunction37 and altered autonomic function38, all of which 
may blunt the blood flow response to exercise. This may potentially explain why a fair 
proportion of the findings observed in the reported studies do not replicate simulated 
mathematical models based on exercise hyperemia. 
 
Practical Implications for Practitioners      
 Despite concerted clinical efforts to reduce phosphate levels, many patients fail to 
obtain target values with a large number of limitations to currently implemented interventions 
including poor adherence to the large pill burden of phosphate binders39. The findings of this 
review suggest that intradialytic exercise may be a potential adjunct therapy for patients with 
inadequate phosphate control. 
For practitioners looking to implement intradialytic exercise for improved phosphate 
removal, the current evidence would suggest intradialytic aerobic cycling at a light to moderate 
intensity exercise (Rating of Perceived Exertion 9 to13 on the Borg 6 to 20 scale) during most 
if not all weekly dialysis sessions. While most studies have implemented exercise during the 
first two hours of dialysis, a few have safely implemented exercise during the third hour16,21,26.  
As opposed to phosphate, dialytic potassium clearance is typically efficient and 
therefore its removal poses less of a clinical challenge. Based on the findings reported herein 
that intradialytic exercise reduces serum potassium levels and increases potassium removal, it 
is important to also consider that hypokalemia is also associated with mortality in dialysis 
patients12. Whilst intradialytic exercise may be beneficial for hyperkalemic patients, patients on 
lower potassium baths should be monitored for subsequent hypokalemia.       
 To reduce the risk of episodic hypotension following exercise, a prolonged cool down 
should be implemented and the ultrafiltration rate can be reduced to minimum during the last 
10 minutes of exercise and throughout the cool down. An emergency clinical algorithm for 
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episodic hypotension should be established and known by all health care professionals 
working in the dialysis unit. Patients who experience intradialytic cramping should try to 
exercise earlier in the dialysis session before they are close to achieving their dry weight.  
Exercise should be supervised by a nurse, physical therapist or clinical exercise 
physiologist who monitors hemodynamic responses to exercise and checks blood glucose 
levels before and after exercise in diabetic patients. The addition of an exercise program to an 
outpatient dialysis unit would therefore likely require an expansion of the clinical staff to 
provide accurate training and supervision of exercise.  
 
Limitations  
 A limitation of this review is that it did not calculate weighted scores for outcomes based 
on the sample size of each study. Due to the indefinite findings in relation the effects of 
exercise on small molecule toxin clearance, this review should be followed up with a meta-
analysis to provide more detailed and objective analyses of the data.   
 
Future Areas for Research          
As with many other areas in the field, future research is needed to refine the parameters 
of the exercise prescription and establish the minimum dose required to elicit the most 
beneficial effect on solute removal. In addition, the effects of intradialytic exercise on the 
kinetics and clearance of the more toxic middle molecules and protein bound solutes remains 
to be established.  
The majority of patients included in these studies already reported an adequate dialysis 
with a Kt/Vurea of ≥1.2. Whether intradialytic exercise could be more effective for improving 
dialysis adequacy in patients with a lower Kt/Vurea who are have a higher risk of hospitalization 
and mortality is unknown. 
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Finally, phosphate control contributes substantially to the pill burden of this patient 
population with patients taking between six to twelve phosphate binders per day39. Non-
adherence to phosphate binders increases with the number of pills prescribed per day, 
contributing to poor phosphate control39. Based on the beneficial effects of intradialytic 
exercise on phosphate removal, future studies aimed at improving patient centered outcomes 
should investigate whether intradialytic exercise could help alleviate the pill burden in these 
patients.        
 
Conclusions 
In summary, it remains unclear whether intradialytic exercise is effective for improving 
dialysis adequacy in terms of Kt/Vurea or small molecule uremic toxin clearance. Supervised, 
light to moderate aerobic cycling during dialysis appears to be beneficial for increasing 
phosphate removal and may be an effective adjunct therapy for patients failing to meet clinical 
phosphate targets. Further work is required to establish the effect of intradialytic exercise on 
other uremic toxins such as middle molecules and protein bound solutes. In addition, research 
aimed at establishing the most effective exercise prescription parameters for improved solute 
clearance is warranted.  
It should also be noted that KDOQI have recently emphasized the need to expand the 
concept of dialysis adequacy to include and prioritize the improvement of quality of life40. 
Intradialytic exercise has consistently proven to be efficacious at improving patient’s physical 
and mental quality of life and, in this respect, it should be considered as an adjunctive 
therapeutic intervention for dialysis adequacy.  
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Figure 1. Flow of literature search. 
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Table 1. Markers of solute removal and kinetics included in data extraction 
Markers of Solute Removal and Kinetics 
Single pool Kt/Vurea -ln(Ct/C0 -0.0083 x T) + (4-3.5 x Ct/C0) x dBW/BW 
Equilibrated Kt/Vurea -ln(Ct30/C0 -0.0083 x T) + (4-3.5 x Ct30/C0) x dBW/BW 
Reduction Ratio (%) 100 x ((C0 – Ct)/C0) 
Rebound Ratio (%) 100 x ((Ct30/C0) / (C0/Ct)) 
Spent Dialysate Content Total Dialysate Sampling (TDS) 
Partial Dialysate Sampling (PDS) 
Continuous Sampling of Spent Dialysate (CSSD) 
Clearance Time T x ln(Ct30/C0) / ln(C0/ Ct30) 
BW, post dialysis weight (kg); C0, pre-dialysis blood urea nitrogen; Ct, post dialysis blood urea nitrogen; Ct30, 30-
minute post dialysis blood urea nitrogen; T, dialysis time; dBW, body weight loss during dialysis (kg). 
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Table 2. Studies investigating intradialytic exercise for dialysis adequacy as a primary outcome measure in adult maintenance 
hemodialysis patients  
Author Design Groups Intervention Outcome Measures Difference 
(% change) 
Effect Size 
 
Acute Interventions 
 
Bohm  
(2017)13 
Randomized 
Controlled 
Trial 
Exercise 
Control  
(N = 30) 
AAerobic (cycling) 
B  1 trial 
C 60-70% HRmax;              
13-14 RPE  
D 30 minutes  
E n/a  
F 60-90 minutes 
 
Urea  
Serum (mg/dL) 
 
Dialysate Content (ml/min;TDC) 
 
Creatinine  
Serum (md/dL) 
 
 
Dialysate Content (ml/min;TDC) 
 
Phosphate 
Serum (mg/dL) 
 
 
Dialysate Content (ml/min;TDC) 
 
Potassium  
Serum (m/EqL) 
 
 
Dialysate Content (ml/min) 
 
Exercise + 3.60 
Control -2.40 
 
Exercise +0.55 
 
 
Exercise +3.19 
Control -1.13  
 
Exercise +2.44 
 
 
Exercise +6.87 
Control -4.62  
 
Exercise -10.10 
 
 
Exercise +6.27 
Control -3.16 
 
Exercise -9.37 
 
0.50(Medium) 
 
 
0.08 (Trivial) 
 
 
0.2 (Small) 
 
 
0.2 (Small) 
 
 
0.5 (Medium)  
 
 
-1.0 (Large) 
 
 
1.2 (Large) 
 
 
? 
Farese 
(2008)14 
Randomized 
Crossover 
Exercise 
Control  
TEMS 
(N = 9) 
A Aerobic (cycling) 
B 3 trials 
C Passive  
D 20 minutes  
E n/a  
F ?  
 
Urea 
spKt/V 
 
eKt/V 
 
Reduction Ratio (%) 
 
Dialysate Content (mg/dL;CSSD) 
 
 
Exercise +2.92 
 
Exercise +2.76 
 
Exercise +1.32 
 
Exercise +33.33 * 
 
 
0.2 (Small)  
 
0.2 (Small) 
 
0.2 (Small) 
 
1.3 (Large) 
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Phosphate   
Dialysate Content (mg/dL; CSSD) 
 
Exercise +30.99 * 
 
1.4 (Large)  
Giannaki 
(2011)15 
Crossover Exercise 
Control  
(N = 10) 
A Aerobic (cycling)  
B 1 session 
C 40% Max Exercise 
Capacity 
D 180 minutes  
E n/a  
F 30-210 minutes 
Urea 
spKt/V 
 
Reduction Ratio (%) 
 
Creatinine 
Reduction Ratio (%) 
 
Exercise +20.18 * 
 
Exercise +11 * 
 
 
Exercise +26 * 
 
7.3 (Large)  
 
?  
 
 
?  
Kirkman 
(2013)16 
Randomized 
Crossover 
Exercise 
Control  
Extra 
Time  
(N = 11) 
A Aerobic (cycling) 
B 2 sessions  
C 90% Aerobic 
Threshold  
D 60 minutes  
E n/a  
F 120-180 minutes  
 
Urea 
eKt/Vurea 
 
 
spKt/Vurea 
 
 
Reduction Ratio (%) 
 
Urea Rebound Ratio (%) 
 
Dialysate Content (mmol;CSSD) 
 
Creatinine  
Reduction Ratio (%) 
 
Rebound Ratio (%) 
 
Dialysate Content (µmol; CSSD) 
 
Beta-2-Microglobulin 
Reduction Ratio (%) 
 
Rebound Ratio (%) 
 
Dialysate Content (mg; CSSD) 
 
Phosphate  
Reduction Ratio (%) 
 
 
Exercise +2.26 
 
 
Exercise +1.99 
 
 
Exercise +1.37 
 
Exercise -16.67 
 
Exercise +1.41 
 
 
Exercise +1.52 
 
Exercise 0.00 
 
Exercise +0.62 
 
 
Exercise +6.00 
 
Exercise -31.25 
 
Exercise +9.29 
 
 
Exercise +18.00 * 
 
 
0.2 (Small) 
 
 
0.2 (Small)  
 
 
0.0 (Nil) 
 
0.0 (Nil 
 
0.04 (Trivial) 
 
 
0.4 (Small) 
 
0.0 (Nil) 
 
0.007 (Trivial) 
 
 
0.3 (Small)  
 
0.5 (Medium)  
 
0.2 (Small)  
 
 
0.5 (Medium)  
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Rebound Ratio (%) 
 
Dialysate Content (mmol;CSSD) 
Exercise -23.08 
 
Exercise +27.27 
0.4 (Small) 
 
0.9 (Large) 
Kong  
(1999)3 
Randomized 
Crossover 
Exercise 
Control  
(N = 11) 
A Aerobic (cycling)  
B 1 session  
C 25-75 Watts  
D 60 minutes  
E n/a  
F ?  
 
Urea 
eKt/V 
 
Reduction Ratio (%) 
 
Rebound Ratio (%) 
 
Clearance Time (min) 
 
Creatinine  
Reduction Ratio (%) 
 
Rebound Ratio (%) 
 
Clearance Time (min) 
 
Potassium  
Rebound Ratio (%) 
 
Exercise +15.00 * 
 
Exercise +7.94 * 
 
Exercise -12.10 * 
 
Exercise -21.57 * 
 
 
Exercise +11.76 * 
 
Exercise -18.87 * 
 
Exercise -29.47 * 
 
 
Exercise -29.03 * 
 
2.21 (Large) 
 
?  
 
?  
 
?  
 
 
?  
 
?  
 
?  
 
 
? 
Leung 
(2004)19 
Randomized 
Crossover 
Exercise 
Control 
(n=15) 
A Aerobic (cycling)  
B 1 session  
C RPE 3  
D 60 minutes  
E n/a  
F ?  
Urea 
Rebound Ratio (%) 
 
Dialysate Content (mmol; PDS) 
 
Exercise -11.16  
 
Exercise +5.99 
 
0.2 (Small) 
 
0.3 (Small) 
Orcy  
(2014)18 
Randomized 
Crossover 
Exercise 
Control  
(N = 22) 
AAerobic (cycling) 
B 3 sessions 
C RPE 13;  
< 80% HRmax  
D 60 minutes  
E n/a  
F 0-120 minutes 
 
 
Urea 
spKt/V 
 
Rebound Ratio (%) 
 
Dialysate Content (CSSD) 
 
Creatinine 
Rebound Ratio (%) 
 
Dialysate Content (CSSD) 
 
 
Exercise -0.77 
 
Exercise -18.18 
 
Exercise -8.32 
 
  
Exercise 0.00 
 
Exercise 0.00 
 
 
-0.05 (Trivial) 
 
? (?) 
 
? (?) 
 
 
0.0 (Nil) 
 
0.0 (Nil) 
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Phosphate  
Rebound Ratio (%) 
 
Dialysate Content (CSSD) 
 
Potassium  
Rebound Ratio (%) 
 
Dialysate Content (CSSD) 
 
Exercise -7.41 
 
Exercise +9.80 
 
 
Exercise +2.63 
 
Exercise +3.76 
 
?  
 
?  
 
 
?  
 
?  
Vaithilinga
m  
(2004)17 
 
 
Randomized 
Crossover 
Exercise  
Control  
Extra 
Time 
(N = 12) 
AAerobic (cycling)  
B 3 sessions 
C ?  
D 30-60 minutes  
E n/a  
F ?  
 
Urea 
spKt/V 
 
Reduction Ratio 
 
Dialysate Content (mg; PDS) 
 
Phosphate  
Serum (mg/dL) 
 
Dialysate Content (mg; PDS) 
 
Exercise 0.00 
 
Exercise +2.78 
 
Exercise +6.06 
 
 
Exercise -3.51 
 
Exercise +9.16 * 
 
0.0 (Nil)  
 
0.2 (Small) 
 
0.2 (Small)  
 
 
-0.2 (Small) 
 
0.4 (Small) 
 
Chronic Interventions 
 
Adam  
(2017)20 
Randomized 
Controlled 
Trial 
Exercise 
Control 
(N = 34) 
A Aerobic  
B ? 
C HR 100bpm  
D 60 minutes  
E 24 weeks  
F 1st 15 min/hour 
Urea 
spKt/V 
 
 
Serum (mg/dL) 
 
Creatinine 
Serum (mg/dL) 
 
Potassium 
Serum (mEq/L) 
 
 
Exercise +16.67 
Control      0 
 
Exercise -41.86 
Control    12.66 
 
Exercise -34.74 
Control   -2.93 
 
Exercise -5.12 
Control   -5.41 
 
1.5 (Large) 
 
 
1.09 (Large) 
 
 
0.1 (Trivial) 
 
 
0.0 (Nil) 
Kern  
(2009)21 
1 Group 
Intervention 
Exercise  
(N = 12) 
 
A Resistance  
B 2-3days/week  
C ?  
D 60 minutes  
Urea 
spKt/V 
 
 
Exercise +7.97 * 
 
0.2 (Small) 
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E 8 weeks  
F 0-180 minutes  
Makhloug
h (2012)22 
Randomized 
Controlled 
Trial 
Exercise 
Control  
(N = 47) 
A Range of Motion  
B 3days/week  
C ?  
D 15 minutes  
E 8 weeks  
F 0-30 minutes  
Phosphate  
Serum (mg/dL) 
 
Potassium  
Serum (mg/L) 
 
 
Exercise +192.96 * 
Control   +0.57 
 
Exercise -11.88 * 
Control   -3.01 
 
 
1.0 (Large)  
 
 
-0.3 (Small) 
Mohseni 
(2013)23 
Randomized 
Controlled 
Trial 
Exercise 
Control  
(N = 50) 
A Range of Motion  
B 3days/week  
C ?  
D 15 minutes  
E 8 weeks  
F 0-120 minutes 
Urea 
spKt/V 
 
 
Reduction Ratio (%) 
 
Exercise +33.33 * 
Control   +5.56 
 
Exercise +50.00 * 
Control     0.00 
 
0.7 (Medium) 
 
 
1.00 (Large) 
Musavian 
(2015)24 
Crossover Exercise 
(Active) 
 
Exercise 
(Passive) 
 
Control  
 
(N = 18) 
AAerobic(cycling)  
B 3days/week  
C ? 
D 30 minutes 
E 8 weeks 
F 0-120 minutes 
AAerobic(cycling)  
B 3 days/week  
C  Passive 
D 30 minutes 
E 8 weeks 
F 0-120 minutes 
Urea 
spKt/V 
 
 
Reduction Ratio (%) 
 
Phosphate  
Serum (mg/dL) 
 
Potassium  
Serum (mEq/L) 
 
 
Passive +9.16 
Active    -4.32 
 
Passive +1.99 
Active    -3.33 
 
Passive -0.40 
Active    -13.2 
 
Passive 0.00 
Active    -9.74 * 
 
 0.4 (Small)  
-0.2 (Small)  
 
 0.2 (Trivial) 
-0.3 (Trivial) 
 
-0.03 (Trivial) 
-0.7 (Medium)  
 
 0.0 (Nil) 
-0.5 (Medium) 
Parsons 
(2004)25 
Randomized 
Controlled 
Trial 
Exercise 
Control  
(N = 13) 
AAerobic(cycling)  
B 3 days/week  
C 40-50% WLmax  
D 45 minutes  
E 8 weeks  
F 0-180 minutes 
 
Urea 
spKt/V 
 
 
eKt/V 
 
 
Serum (umol/L) 
 
 
Dialysate Content (mmol; PDS)  
 
 
Exercise 0.00 
Control   -4.47 
 
Exercise +0.79 
Control    -3.17 
 
Exercise -2.29 
Control   +8.33 
 
Exercise +15.00 * 
Control    -1.00 
 
 0.2 (Small)  
 
 
 0.1 (Trivial)  
 
 
-0.2 (Small) 
 
 
 1.1 (Large) 
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Creatinine  
Serum (umol/L) 
 
Potassium  
Serum (mEq/L) 
 
 
Exercise +0.59 
Control   +1.19 
 
Exercise -6.38 * 
Control  +2.13 
 
-0.03 (Trivial) 
 
 
-0.7 (Medium) 
 
Parsons 
(2006)26 
1 Group 
Intervention 
Exercise 
(N = 13) 
A Aerobic (cycling or 
mini stepper)  
B 3 days/week  
C self-paced  
D 60 minutes  
E 20 weeks  
F 0-120 minutes 
Urea 
spKt/V 
 
Serum (umol/L) 
 
Reduction ratio (%) 
 
Exercise +15.49 * 
 
Exercise +3.30 
 
Exercise +7.11 * 
 
 0.9 (Large)  
 
 0.2 (Small) 
 
 0.8 (Large) 
CSSD, continuous sampling of spent dialysate; eKt/V, equilibrated Kt/V; PDS, partial dialysate sampling; spKt/V, single pooled 
Kt/V; TEMS, transcutaneous electrical muscle stimulation; ?, information not available from paper. 
 A, exercise modality; B exercise frequency; C, exercise intensity; D, exercise duration; E, exercise time during dialysis; F, length 
of exercise intervention; *, statistical significance (p < 0.05). 
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Table 3. Study Bias Risk 
First Author 
Bias 
Selection Detection Attrition   Performance 
Overall 
Score 
Adam (2017)20 3 1 1 2 B 
Bohm (2017)13 3 1 1 3 B 
Farese (2008)14 2 1 3 3 B 
Giannaki (2011)15 1 1 1 3 C 
Kern (2009)21 1 1 3 1 C 
Kirkman (2013)16 3 3 3 3 A 
Kong (1999)3 2 1 1 3 B 
Leung (2004)19 2 1 3 3 B 
Makhlough (2012)22 3 3 1 2 B 
Mohseni (2013)23 3 3 3 2 B 
Musavian (2015)24 1 1 3 2 B 
Orcy (2014)18 3 3 3 3 A 
Parsons (2004)25 2 1 3 2 B 
Parsons (2006)26 1 1 3 1 C 
Vaithilingam (2004)17 2 1 1 3 B 
 
 
